<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th><p><bold>Driver name</bold></p> </th><th><p><bold>Description</bold></p> </th><th><p><bold>Reference</bold></p> </th></tr></thead><tbody><tr><td><p>G14-Gal4</p></td><td><p>All somatic muscles, early expression; on chromosome 2</p></td><td><p>(<xref ref-type="bibr" rid="bib1">Aberle et al., 2002</xref>)</p></td></tr><tr><td><p>MHC-Geneswitch (MHCGS)</p></td><td><p>Chemically-inducible variant on the MHC driver.</p><p>Used in this and in <xref ref-type="bibr" rid="bib64">Teodoro et al. (2013)</xref> without</p><p>chemical induction by RU-486, as its &#8216;leakiness&#8217; inpost-</p><p>embryonic stages is sufficient to allow</p><p>expression of transgenic HA-Ral and GFP-FLN90;</p><p>on chromosome 3</p></td><td><p>(<xref ref-type="bibr" rid="bib43">Osterwalder et al., 2001</xref>)</p></td></tr></tbody></table></table-wrap>